Diabetes, Metabolic Syndrome, Obese, Sleep Apnea Syndromes
Conditions
Keywords
Sleep Apnea Syndromes, Diabetes, Withings Sleep analyzer, Epworth, Berlin
Brief summary
Diabetes, obesity and metabolic syndrome are closely linked to sleep apnea syndrome. Indeed, diabetic and/or obese patients present an increased risk of sleep apnoea syndrome (SAS), with a prevalence estimated at between 10 and 22%, depending on the study, and most of them requiring treatment with Continuous Positive Airway Pressure (CPAP). In this sub-population of patients, only between 40% and 50% benefit from CPAP.
Detailed description
There is therefore an under-referral of diabetic patients to treatment, perhaps linked to the way care is organized, which clogs up the circuit and slows down or even prevents access to care. The investigators would like to test a new organization of care to facilitate and intensify this screening.
Interventions
DEVICEWITHINGS Sleep Analyzer
Potentially eligible patients will be offered to participate in the study, the information leaflet will be given to them and the informed consent form will be signed if the patient agrees to participate in the study. In hospitalization in Endocrinology: * Realization of the current care report * Including systematic achievement of EPWORTH and BERLIN scores * Activation of the WSA throughout the duration of the hospitalization * Completion of a feasibility questionnaire for the team * Quantification of the non-usable screening technique * Completion of a patient experience questionnaire at the end of the stay * In the event of published positive criteria either for the BERLIN questionnaires, EPWORTH questionnaires or WSA, the patient will be referred to the VISAS center for definitive diagnostic evaluation by polygraphy or polysomnography.
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients over 18 years old * Diabetes Mellitus (Type 1 or 2), or obesity (BMI\>30kg/m²) or metabolic syndrome * Hospitalized for at least one night in the Endocrinology department * Affiliated or entitled to a social security scheme * Having received informed information about the study and having co-signed, with the investigator, the informed consent form for participation in the study
Exclusion criteria
* Known and/or treated OSAS-type respiratory pathology * No signature of the informed consent form * Minor or adult patients under guardianship or curatorship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| patients real positive for each screening technique | Day 2 | Percentage of patients real positive for each screening technique: BERLIN and EPWORTH score and Withings Sleep Analyzer addressed for polysomnography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient's experience with the use of Withings Sleep Analyzer | Day 2 | Patients' experience is evaluated using a questionnaire with the following possible answers: yes a lot, yes a little, not at all. |
| Nurse's satisfaction with the use of Withings Sleep Analyzer | 3 months | Nurse's satisfaction is evaluated using a questionnaire with the following possible answers: yes a lot, yes a little, not at all. |
| Number of tests | Day 2 | Number of positive tests / Number of analyzable test for screening for each type of test |
Countries
France
Outcome results
None listed